Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Alaunos Therapeutics (TCRT) Interest Coverage Ratio (2021 - 2023)

Historic Interest Coverage Ratio for Alaunos Therapeutics (TCRT) over the last 3 years, with Q2 2023 value amounting to 7.47.

  • Alaunos Therapeutics' Interest Coverage Ratio rose 4009.97% to 7.47 in Q2 2023 from the same period last year, while for Mar 2024 it was 24.66, marking a year-over-year decrease of 13361.12%. This contributed to the annual value of 17.84 for FY2023, which is 6260.34% down from last year.
  • Per Alaunos Therapeutics' latest filing, its Interest Coverage Ratio stood at 7.47 for Q2 2023, which was up 4009.97% from 10.75 recorded in Q1 2023.
  • Alaunos Therapeutics' 5-year Interest Coverage Ratio high stood at 7.47 for Q2 2023, and its period low was 50.22 during Q3 2021.
  • Moreover, its 3-year median value for Interest Coverage Ratio was 11.61 (2022), whereas its average is 15.98.
  • As far as peak fluctuations go, Alaunos Therapeutics' Interest Coverage Ratio skyrocketed by 8043.18% in 2022, and later soared by 1719.68% in 2023.
  • Over the past 3 years, Alaunos Therapeutics' Interest Coverage Ratio (Quarter) stood at 14.62 in 2021, then surged by 35.23% to 9.47 in 2022, then increased by 21.06% to 7.47 in 2023.
  • Its Interest Coverage Ratio was 7.47 in Q2 2023, compared to 10.75 in Q1 2023 and 9.47 in Q4 2022.